echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Professor Yang Qingwu of Stroke Military Academy: Is the acute basilar artery occlusion still treated in conservative medicine?

    Professor Yang Qingwu of Stroke Military Academy: Is the acute basilar artery occlusion still treated in conservative medicine?

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Acute basilar artery occlusion (BAO) is a rare but catastrophic condition that accounts for 1% of all ischemic strokes and 5% of large vessel occlusion (LVO) strokes
    .


    Despite recent progress in the treatment of acute stroke, up to 68% of patients with acute BAO die or remain severely disabled


    Stroke vessels Although recent progress has been made in the treatment of acute strokes, up to 68% of patients with acute BAO die or remain severely disabled


    It has been confirmed that early recanalization of occluded arteries in acute stroke is associated with a good functional prognosis


    In May 2020, Qingwu Yang from Xinqiao Hospital, China, etc.


    The BASILAR registration is a nationwide prospective non-randomized study conducted in China.
    From January 2014 to May 2019, patients with acute basilar artery occlusion who received endovascular treatment or conventional treatment were continuously recruited
    .


    Recently, Professor Yang Qingwu from China's Third Military Medical University reported in the Stroke magazine the clinical follow-up results of these patients one year later


    The main result of the trial is the modified Rankin scale one year later, using sequential logistic regression analysis to adjust the pre-specified prognostic factors to assess the prevalence
    .


    Secondary results included the result group (0-1, 0-2, or 0-3) based on the modified Rankin scale and all-cause death after one year


    Of the 829 patients initially registered with BASILAR, one-year data were available for 785 patients (94.
    7%)
    .


    In general, the distribution of the results of the revised Rankin Scale suggests that endovascular treatment, rather than traditional treatment, is beneficial for patients with basilar artery occlusion to obtain a better prognosis (OR=4.


    In general, the distribution of the results of the revised Rankin Scale suggests that endovascular treatment, rather than traditional treatment, is beneficial for patients with basilar artery occlusion to obtain a better prognosis (OR=4.


    Diagram of the main outcomes of the BASILAR trial

    It can be seen that the beneficial effect of endovascular treatment on the functional outcome of patients with acute basilar artery occlusion after one year is similar to the 90-day report in the original study
    .

    It can be seen that the beneficial effect of endovascular treatment on the functional outcome of patients with acute basilar artery occlusion after one year is similar to the 90-day report in the original study
    .


    It can be seen that the beneficial effect of endovascular treatment on the functional outcome of patients with acute basilar artery occlusion after one year is similar to the 90-day report in the original study


    references:

    One-Year Outcome After Endovascular Treatment for Acute Basilar Artery Occlusion.


    One-Year Outcome After Endovascular Treatment for Acute Basilar Artery Occlusion.
    Https://doi.
    org/10.
    1161/STROKEAHA.
    120.
    033658.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.